Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ABL Bio Inc
Original Assignee
ABL Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ABL Bio IncfiledCriticalABL Bio Inc
Publication of WO2026084392A1publicationCriticalpatent/WO2026084392A1/fr
La présente divulgation concerne un anticorps anti-CLDN6 et un fragment de liaison à l'antigène de celui-ci. En outre, la présente divulgation concerne une utilisation thérapeutique de l'anticorps anti-CLDN6 ou du fragment de liaison à l'antigène de celui-ci.
PCT/KR2025/0160432024-10-142025-10-13Anticorps anti-claudine 6 et son utilisation
PendingWO2026084392A1
(fr)
Protéine de fusion comprenant un anticorps anti-tigit, l'interleukine-15 et le domaine alpha sushi du récepteur de l'interleukine-15 et son utilisation